Closed · HT942525PRCRPCDAFRO · CFDA 12.420 · Discretionary
DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option
Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 3, 2025
- Close date
- 12
- Expected awards
The verdict
DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 12 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 12
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option - is cataloged under number HT942525PRCRPCDAFRO and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on May 22, 2025 and last updated on June 11, 2025. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $6.7 million in total estimated funding for this announcement. It expects to issue 12 awards. If the agency funds the expected 12 awards from the $6.7 million estimated pool, the average award works out to roughly $560,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on July 3, 2025. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
July 3, 2025
Posted
May 22, 2025
Est. Total Funding
$6,720,000
Expected Awards
12
Instrument
Grant
Description
Summary: The fiscal year 2025 (FY25) Peer Reviewed Cancer Research Program (PRCRP) Clinical Development Award - Fellow and Resident Option (CDA-FRO) supports the advancement of cancer research through development of early-career investigators. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. The proposed research should address a critical problem in at least one of the FY25 PRCRP topic areas and at least one of the FY25 PRCRP strategic goals and should be designed to advance cancer research and/or improve patient care.Distinctive Features: There are two distinct early-career development options: the Fellow Option and the Resident Option. For the Fellow Option the PI must be an early-career researcher or physician-scientist (referred to as a Fellow) within seven years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training or on family medical leave). For the Resident Option the PI must be an early-career clinician performing their residency with an interest in becoming a physician-scientist.Career Guide: Inclusion of a Career Guide, experienced cancer researcher, as demonstrated by a strong record of funding and publications, is required for both the Fellow Option and the Resident Option. The Career Guide must demonstrate a commitment to advancing the PI’s career in cancer research.Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Dept. of the Army -- USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Department of Defense HIV/AIDS Prevention Program
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |